For internal use only, please do not circulate outside of Otsuka
p1. p2. p3. p4. p5. p6.
JOB PROFILING SALES UPDATES MEDICAL PAGE
MARKETING BEST PRACTICES WORKSHOP
REGIONAL SALES MEETINGS
p10. HR CORNER p10. CAREER OPPORTUNITIES p11. WELCOME p11. REWARD AND RECOGNITION p11. DATES TO REMEMBER p12. ABILIFY MYCITE® APPROVAL p12. CUSTOMER REVOLUTION p12. WORDS FROM A JINARC PATIENT p13. ALBERTA KIDNEY MARCH p14. PHOTO GALLERY
THE GM CORNER
2017 was all about moving forward…and boy, did we ever take that to heart! It is incredible to think that the year is almost over. And what a year it has been! The strategy this year was to accomplish two things – continue to make our culture EVEN stronger and for each and every one of us to clear the path to the customers EVERY day! I am so energized by the stories I heard all year - terrific examples of working on our culture, inspiring stories of how we have elevated the customer experience. I encourage you all to go on our Intranet and read the amazing stories for yourselves and continue to think about how you can contribute to the Customer Revolution! There are so many outstanding accomplishments that made 2017 successful, not the least of which is that each and every one of our promoted products met or, in fact, exceeded financial commitments. We are so close to achieving BLOCKBUSTER STATUS – or $100 Million in revenue! What an achievement after only 7 years! In fact, I got feedback directly from the OCPI Board of Directors, as well as the US and Japan, that they congratulate, thank and acknowledge all of OCPI for delivering consistent performance, and for contributing so much profit to the company. The rest of the Otsuka world has taken notice of OCPI – and they are eager to learn from our successes! Think of the HUGE achievements of 2017 – that everyone at OCPI contributed to! • We rolled out Performance Management – a new way of coaching and developing our amazing team! This has been a model for the US who are planning a rollout in 2018, and will be looking at us for inspiration! • A large team of dedicated people worked on the Abilify DIN transfer – our baby has come back to Otsuka as of December 2017!! This was a significant accomplishment and, again, the whole world sat up and took notice! • Abilify Maintena got the bipolar indication which is another important milestone for this amazing product. So many patients have benefited from Abilify Maintena in schizophrenia, and now so many more patients that live with bipolar disorder will also be able to benefit! • REPRISE! Jinarc has had another banner year. With new data that shows that patients a later stage of disease benefit from treatment with Jinarc, even more physicians and patients will have the confidence to delay progression of kidney disease with Jinarc! This team has played a real leadership role in the rollout of the data, especially now that the US is filing Tolvaptan!
Made with FlippingBook - Online catalogs